Murray D. Esler mostly deals with Internal medicine, Endocrinology, Sympathetic nervous system, Blood pressure and Cardiology. All of his Internal medicine and Norepinephrine, Heart failure, Norepinephrine, Essential hypertension and Pathophysiology of hypertension investigations are sub-components of the entire Internal medicine study. His biological study spans a wide range of topics, including Autonomic nervous system, Baroreflex, Heart rate, Epinephrine and Pathophysiology.
His Blood pressure research incorporates themes from Renal artery, Anesthesia, Surgery, Denervation and Renal function. The Surgery study combines topics in areas such as Renal blood flow and Renal sympathetic denervation. His research in Cardiology tackles topics such as Diastole which are related to areas like Resistant hypertension.
Murray D. Esler focuses on Internal medicine, Endocrinology, Sympathetic nervous system, Blood pressure and Cardiology. His study involves Denervation, Heart failure, Norepinephrine, Baroreflex and Essential hypertension, a branch of Internal medicine. His studies deal with areas such as Renal artery, Kidney, Surgery, Catheter and Renal function as well as Denervation.
His Sympathetic nervous system study combines topics from a wide range of disciplines, such as Autonomic nervous system, Pathophysiology, Norepinephrine and Neuroscience. The Ambulatory blood pressure research Murray D. Esler does as part of his general Blood pressure study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science. His research in Cardiology intersects with topics in Resistant hypertension, Renal sympathetic denervation and Diastole.
His scientific interests lie mostly in Internal medicine, Denervation, Blood pressure, Cardiology and Endocrinology. His Denervation research includes themes of Urology, Renal artery, Kidney and Renal function. His Blood pressure research focuses on subjects like Surgery, which are linked to Aldosterone.
The various areas that Murray D. Esler examines in his Cardiology study include Autonomic nervous system, Sympathetic activity, Renal sympathetic denervation and Diastole. His work deals with themes such as Platelet and Single-nucleotide polymorphism, which intersect with Endocrinology. His research integrates issues of Essential hypertension, Norepinephrine and Heart failure in his study of Sympathetic nervous system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial
Murray D. Esler;Henry Krum;Henry Krum;Paul A. Sobotka;Markus P. Schlaich.
The Lancet (2010)
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
Henry Krum;Henry Krum;Markus Schlaich;Robert Whitbourn;Paul Sobotka.
The Lancet (2009)
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
Gregory J. Hasking;Murray D. Esler;Garry L. Jennings;Deborah Burton.
Circulation (1986)
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
Markus P. Schlaich;Paul A. Sobotka;Henry Krum;Elisabeth Lambert.
The New England Journal of Medicine (2009)
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
M Esler;G Jennings;G Lambert;I Meredith.
Physiological Reviews (1990)
Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover.
M Esler;G Jennings;P Korner;I Willett.
Hypertension (1988)
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension A Pilot Study
Felix Mahfoud;Markus Schlaich;Ingrid Kindermann;Christian Ukena.
Circulation (2011)
"Stress" and coronary heart disease: psychosocial risk factors.
Stephen J Bunker;David M Colquhoun;Murray D Esler;Ian B Hickie.
The Medical Journal of Australia (2003)
Adverse consequences of high sympathetic nervous activity in the failing human heart
David M. Kaye;Jeffrey Lefkovits;Garry L. Jennings;Peter Bergin.
Journal of the American College of Cardiology (1995)
Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.
Markus P. Schlaich;Elisabeth Lambert;David M. Kaye;Zygmunt Krozowski.
Hypertension (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Western Australia
National Heart Foundation of Australia
The Alfred Hospital
Monash University
University of Bremen
Teesside University
TU Dresden
The Alfred Hospital
Baker IDI Heart and Diabetes Institute
University of Michigan–Ann Arbor
University of Maryland, Baltimore County
Microsoft (United States)
Northeastern University
East China Normal University
Universität Hamburg
Tel Aviv University
The Ohio State University
University of Oxford
Uppsala University
Leiden University Medical Center
Veterans Health Administration
University of Valencia
Aarhus University
Peking University
New York University
Toronto General Hospital